Both stocks are in negative territory this year, but upcoming earnings reports could change how investors view their ...

Over the last six months, GE HealthCare’s shares have sunk to $68.00, producing a disappointing 7.9% loss - a stark contrast ...

The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.

Oct 5 (Reuters) - Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in cash, in a move that strengthens its ability to manufacture and ...

GE HealthCare Technologies has seen its share price slide this year, which naturally pushes investors to ask whether the ...

The cash deal to acquire the PET radiopharmaceuticals CMO from Trilantic North America is expected to close in H1 2027.

Acquisition of Sofie Biosciences is second big purchase for medical imaging specialist after split from General Electric ...

Integrated artificial intelligence (AI) and advanced tools improve image quality and exam speed to help providers make accurate diagnoses and tailor precision care for women Latest Voluson Signature ...

Rodolphe Katra has joined from Medtronic to lead GE HealthCare’s efforts to connect devices, software and data.

Catholic Health, a New York-based healthcare system, on Thursday announced a 10-year partnership worth approximately $500M with GE HealthCare (GEHC) to modernize its operations in the areas of imaging ...

GE HealthCare is positioned for a valuation re-rating. The SOFIE Biosciences acquisition enhances its precision medicine ...

GE HealthCare agreed to acquire SOFIE Biosciences for $945 million in cash, expanding its U.S. PET radiopharmaceutical manufacturing and distribution network and strengthening its position in the ...